Risk of new-onset obstructive sleep apnea up to 4.5 years after COVID-19 in the urban population
Abstract
Obstructive sleep apnea (OSA) is linked to cardiovascular, metabolic, and cognitive morbidity.
Although COVID-19 has been associated with long-term respiratory and neurological sequelae...
High prevalence of obstructive sleep apnea in patients with Long-COVID.
Background
Long-COVID (LC) is defined as the persistence of symptoms 12 weeks after the acute COVID infection not explained by any other alternative diagnosis. Its pathophysiology is poorly understood. Obstructive Sleep...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.